The pathogenicity of herpes simplex virus type 2 strain 186, the wild-type (WT) strain, and four temperature-sensitive (ts) mutants was studied after genital inoculation of female guinea pigs. Infection with the WT virus was generally severe, with extensive skin lesions in 89% and mortality in 37% of inoculated animals. Guinea pigs inoculated with ts mutants manifest remarkably mild disease, with lesions occurring in only 16% of the guinea pigs and a mortality rate of 7%. WT virus was recovered from nerve and non-nerve tissues of all acutely infected animals and from the majority of latently infected animals (71%). Virus was isolated from nerve or genital tissues from only 13% of ts mutant-inoculated animals during acute infection and from 7% during latent infection. Three of the seven isolates from mutant-infected animals appeared to be WT virus. Identification of WT and ts mutant isolates was done by biological characterization in selective cell cultures at permissive (330C) and nonpermissive (380C) temperatures. One month after initial infection with WT virus, guinea pigs were challenged with the same virus and were completely resistant to overt clinical disease. Animals inoculated with ts mutants Alb and C2b had mild manifestations of disease after challenge with WT virus; however, the capacity of WT virus to establish latent infection was conserved. Although complement-required neutralizing antibodies were detectable after challenge in animals previously inoculated with mutant virus Alb, C2b, or D6b, there was no significant protection against subsequent infection with WT virus. No complement-required neutralizing antibodies were detected in F3b animals after challenge. The present study of WT and ts mutants of herpes simplex virus type 2 in the guinea pig model provides a means for better understanding the mechanisms of pathogenesis and latency after genital infection.
Herpes simplex virus (HSV) has been shown to establish latent and recurrent infections in humans (1, 27) and in various experimental animal models (9, 15, 17, 18, 21, 23, 28) . Although the pathogenesis of wild-type (WT) HSV has been extensively studied, the mechanism by which HSV enters the latent state and undergoes reactivation remains largely unknown (22) .
As an approach to elucidate the nature of HSV and the enigma of latent infection, several temperature-sensitive (ts) mutants of HSV type 1 (HSV-1) and HSV-2 have been selected and characterized by molecular and biochemical methods (3, 16) . HSV-1 (7, 12) and HSV-2 (5, 29) ts mutants have been studied in several experimental animal species to correlate in vitro host range characteristics and biochemical properties with pathogenicity (5, 7) . Studies of ts mutants of HSV-2 in guinea pigs have not been reported. It was the aim of the present study to characterize in tissue culture various ts mutants of HSV-2 and to determine their pathogenicity in an animal model of experimental genital infection. In addition, attempts were made to determine whether primary infection with any ts mutants would confer host resistance to subsequent infection with HSV-2 WT virus and to correlate the known biochemical defects of mutant strains with their capacity to provide protection.
Previous studies of HSV-2 by other workers showed that the female guinea pig had been infected successfully by intravaginal inoculation (6, 8, 11, (17) (18) (19) . In the early work by Lukas et al. (10) , the guinea pig was shown to be a suitable experimental model for genital herpesvirus infection. In guinea pigs, clinical symptoms, virus isolation from vaginal swabs after inoculation, recovery of virus from tissues, and the production of neutralizing antibodies to HSV-2 were reminiscent of the clinical and immunological spectrum of HSV infection as seen in humans.
Scriba used the guinea pig to demonstrate chronic, latent infections with spontaneously recurring lesions at the sites of initial inoculation (17, 18) . Virus was recovered from extraneural tissues in latently infected animals (18) .
Like guinea pigs, Cebus monkeys experienced spontaneous recurrent HSV infections with latency in the sacral dorsal root ganglia after primary vulvovaginitis and seroconversion (8) .
In contrast to the guinea pigs and monkeys, mice have a generally high mortality rate after vaginal HSV infection (25) . Reactivation of virus can be accomplished in vivo after neurectomy (26) , and spontaneous recurrences of clinical disease have been reported in the mouse model (4) .
In view of the previous reports using various animal models, HSV infection in the guinea pig appeared to closely mimic the human situation; therefore, this animal model was selected to examine the pathogenesis of ts mutants of HSV-
2.
MATERIALS AND METHODS Virus stocks. WT HSV-2 strain 186 (14) and four ts mutants of strain 186 (3) were gifts from Priscilla A. Schaffer (Sidney Farber Cancer Institute, Boston, Mass.). These particular mutants were selected because of their reported differences in deoxyribonucleic acid and thymidine kinase (TK) properties at the nonpermissive temperature (3). Virus stocks were prepared in primary rabbit kidney cell monolayers infected at an input multiplicity of 0.05 to 0.1 plaqueforming units/cell. After an adsorption period of 1 hour at 360C, unadsorbed virus was removed. Maintenance medium was added, and infected cultures were incubated at 330C until cytopathic effects were extensive. Virus was harvested by freezing and thawing three times at -70oC, and fluid was clarified by lowspeed centrifugation (225 x g) at 40C for 20 min. The supernatant fluid containing virus was stored at -70'C. Infectivity titers of stock virus were determined by plaque-forming units or 50% tissue culture infective doses in guinea pig embryo (GPE) cell monolayers incubated at 330C.
Initial inoculation of guinea pigs. Young adult (8-week-old), female Hartley guinea pigs were used throughout the study. The vaginal closure membrane was broken, and the external mucosa was slightly abraded with a scalpel. A tuberculin syringe without a needle was used to introduce 0.5 ml of virus into the vaginal vault, which was plugged with soluble Gelfoam (The Upjohn Co.) surgical pads to retain the fluid. To determine the 50% infectious dose of WT virus in vivo, guinea pigs were inoculated with serial 10-fold dilutions of the virus. All guinea pigs were observed daily for clinical manifestations of herpetic infection and death.
Challenge of guinea pigs with WT virus. Thirty-five days after initial inoculation, all guinea pigs received a challenge inoculum of 5. 5 (ii) Guinea pig tissues. Guinea pigs were sacrificed by exsanguination under ether anesthesia. Virus isolation was attempted from nerve and non-nerve tissues during acute infection (8 to 11 days postinoculation), latent infection (33 to 55 days postinoculation), acute infection postchallenge (8 to 11 days after challenge), and latent infection postchallenge (33 to 55 days after challenge). Nerve tissues studied included temporal lobe of brain, trigeminal ganglia, lumbrosacral spinal cord, lumbrosacral dorsal root ganglia, and the lumbrosacral plexus with sciatic nerve. Non-nerve tissues studied included cervix, vagina, and urinary bladder. A 10% (wt/vol) suspension of minced tissue in Hanks balanced salt solution was cocultivated with rabbit kidney cell monolayers (0.2 ml of suspension per culture tube). All inoculated cultures were incubated at 33°C (permissive temperature) and examined for herpesvirus-induced cytopathic effects for 5 to 6 weeks. Isolates were frozen at -70°C for further identification. In selected instances, isolates were identified by plaque reduction neutralization in primary GPE or chicken embryo (CE) monolayers, using commercially prepared rabbit antiserum against HSV.
Characterization of WT and ts mutants in tissue culture. Virus stocks and isolates from vaginal swabs and tissues were characterized by the cell culture selection plaque technique (13) in Linbro microtest plates (16-mm-diameter well; 24 wells per plate) at permissive (33°C) and nonpermissive (38°C) temperatures. For the plaque assay, primary GPE and CE cell monolayers were used. Preparation of these cell cultures was described previously (13) . Each plate was seeded with two rows each of GPE and CE cells (see Fig. 1 ) and incubated at 37°C in a humidified atmosphere of 5% CO2. When monolayers were confluent, the growth medium was removed, and 0.1 ml of serial 10-fold dilutions of virus suspensions were inoculated in duplicate into plates containing both GPE and CE cells. Virus was adsorbed for 1 hour at 37°C. Overlay medium containing 0.5% methyl cellulose was added, and plates were sealed with clear adhesive. One plate was incubated at the permissive temperature, and the second plate was incubated at the nonpermissive temperature. Three days later, the overlay medium was removed by suction, and infected monolayers were fixed with cold methanol and stained with 2.6% crystal violet in 95% ethanol (13) . For typing of all isolates obtained from guinea pig vaginal swabs and tissues, appropriate stock virus titrations were included as controls.
CRN antibody studies. All guinea pigs were bled by cardiac puncture under ether anesthesia before receiving initial and challenge viruses, and at sacrifice. Complement-required neutralizing (CRN) antibodies in serum were determined by plaque reduction neutralization test, using CE monolayers in microtest plates. Heat-inactivated sera were serially diluted twofold in 0.4 ml of Veronal-buffered saline (pH 7.4); 100 50% tissue culture infective doses of WT virus in 0.2 ml were added to each serum dilution, followed by 0.2 ml of complement dilution containing 8 hemolytic
on January 25, 2018 by guest http://iai.asm.org/ Downloaded from units. After 30 min at room temperature, CE monolayers were inoculated with the virus-serum mixtures (0.2 ml per well) and allowed to adsorb at 370C for 1 h; then the methyl cellulose overlay medium was added. After 3 days at 330C, overlay medium was removed, and the infected CE monolayers were fixed and stained as above.
RESULTS
Characterization of virus strains in cell cultures. GPE and CE cell monolayers inoculated with HSV-2 strain 186 WT stock or ts mutant stocks had different infectivity titers at the two temperatures (Table 1) . WT virus grew equally well at 33 and 380C, with mean titers of 4.6 to 5.0 logo plaque-forming units/0.1 ml in GPE and CE cells. In contrast, the sensitivity of ts mutants to the elevated temperature was evident in GPE cells and was especially remarkable in CE monolayers. In GPE cells, infectivity at the nonpermissive temperature (380C) was 1.2 to 3.0 logo plaque-forming units/0.1 ml lower than at the permissive temperature (330C); however, CE cells at 380C were almost completely refractory to infection with the ts mutants, and few or no plaques were seen.
The plaques of WT 186 at both temperatures were distinct and the infectivity titers were similar in both GPE and CE cell monolayers (Fig.1A) . The plaque size of WT was larger at the nonpermissive temperature than at the permissive temperature in GPE cell monolayers; however, WT produced slightly smaller plaques at 38CC than at 330C in CE monolayers, although the titers were the same. In contrast, ts mutants at 380C grew to titers approximately 2 logo plaque-forming units/0.1 ml lower than at 330C in GPE cells, and the plaques were consistently smaller and more irregular in shape than those of the wild strain (Fig. 1B) . CE monolayers at the nonpermissive temperature were useful for differentiating between WT and mu- Figure 2A shows the genitalia of a normal female guinea pig before the onset of lesions. Within 3 to 7 days postinoculation, herpetic vesicles were present in the genital area. The highest dose of virus generally produced severe infections (Fig. 2B ) which often progressed to ulceration and necrosis. Paralysis of the hind quarters was common. At the lower doses of virus inoculum, clinical disease was milder and fewer deaths occurred ( Table 2 ). In addition, the frequency of virus isolation from the various tissues tested during acute and latent infection was decreased. Secondary bacterial and yeast infections occurred in animals with severe erosions, but no deaths could be attributed to the superinfection. Complete resolution of clinical manifestations required 1 to 6 weeks.
Comparison of clinical manifestations in guinea pigs inoculated with WT and ts mutant virus. The pathogenicity of ts mutants in guinea pigs was significantly different from that of WT virus (see Table 3 ). Eighty-nine percent of animals had lesions, with 37% mortality, after inoculation with WT virus. In contrast, the incidence of lesions in ts mutant-infected animals was low. The ts mutant Alb induced lesions in 15 of 37 animals (40%), whereas C2b, D6b, and F3b produced lesions in 6, 5, and 0% of inoculated animals, respectively. Death in ts mutantinfected animals was infrequent, with mutant C2b having the highest mortality rate (17%) of the four mutants tested. All animals from mutant-inoculated groups were without clinical manifestations before death.
Most remarkable was the mildness of clinical disease produced by mutant strains. Only one to three papules were seen in Alb-infected guinea pigs. Vesicles were minute, with a trace of inflammation at the base of the eruption (Fig. 20) , and all lesions disappeared within 24 as WT. These were found in nerve tissues from one C2b and one D6b animal.
Modification of clinical disease and mortality after challenge with WT virus. The degrees of pathogenicity of WT virus in guinea pigs with and without prior infection with WT or mutant virus were compared (Table 4) . Animals initially inoculated with WT virus provided complete resistance to reinfection with the same virus strain; no deaths occurred after challenge. To rule out age as a factor in resistance to reinfection, six control guinea pigs were matched in age to those in the experimental groups and received only challenge WT virus. Five of six (83%) animals developed severe infections which resulted in five deaths during a period of 13 to 23 days postinoculation ( (ii) Various tissues. Guinea pigs which received an initial dose of ts D6b had the highest frequency of WT virus recovered: five of five from the nerve tissues and three offive from non-nerve tissues tested during the acute phase after WT virus challenge. WT virus was recovered from the nerve of one F3b animal during the acute phase postchallenge but not from the eight animals tested during latent phase postchallenge. CRN antibody studies. No guinea pigs had detectable levels of CRN antibodies to WT virus before the initial inoculation with either WT or mutant virus. Table 5 presents the range of CRN antibody titers before challenge with WT (35 days after initial inoculation) and after challenge. Although animals which had been previously infected with WT virus were not tested for CRN antibodies or for virus isolation during the acute phase postchallenge, low-to-moderate (1:5 to 1:40) levels of CRN antibodies were detected before and after challenge during the latent phase postchallenge. Five of six guinea pigs died in the age-matched control group which had not been previously infected with WT virus; therefore, sera were not available for CRN antibody studies.
Of the animals which were initially inoculated with the mutant viruses, only the ts Alb-inoculated group had low levels (1:5 to 1:10) of CRN antibodies before challenge. However, all animals in this group showed a fourfold or greater rise in antibody titers during the acute phase postchallenge (1:20 to 1:80), and these titers dropped back to low levels (1:5 to 1:10) by 35 to 55 days, i.e., during the latent phase postchallenge. C2b-inoculated animals had no detectable levels of antibody before challenge except for one animal which had a titer of 1:5. CRN anti-
on January 25, 2018 by guest http://iai.asm.org/ Downloaded from body titers of 1:40 were detected in some animals during the acute phase postchallenge, and moderate (1:20) titers were evident up to 60 days postchallenge. D6b-inoculated animals had antibody titers of -1:40 during the acute phase and up to 1:20 during the latent phase, respectively, after challenge. In contrast, no CRN antibodies could be detected in sera collected from any of the animals which were initially inoculated with ts F3b.
DISCUSSION
The ts mutants have been used as tools to investigate the complex biochemical nature of HSV-1 and HSV-2 and to determine type-common and type-specific genes and gene functions. Although ts mutants of HSV-1 and HSV-2 have been isolated and phenotypically defined, the biological character of ts mutants has been studied mainly in the central nervous system of experimental animals (5, 7, 12, 24, 29) . Particular mutants of HSV-2 have been partially characterized genetically (2) and biochemically (3), but their pathogenicities in animals had not been investigated before the present studies in a guinea pig model of genital infection.
As a prelude to the in vivo study, the distinctive patterns of plaque formation in GPE and CE cell monolayers produced by WT virus and ts mutants at permissive and nonpermissive temperatures were excellent parameters for identification of ts mutants tested in the animal study. CE cells at the nonpermissive temperature were the most sensitive indicators of ts mutant stock purity since ts mutants grew poorly or not at all in this cell species. Limited growth of ts mutants in GPE cell monolayers at the nonpermissive temperature indicated that these cells were semipermissive for the mutants. Thus, as defined by Koment and Rapp (5), with the ts phenotype apparent only in particular cell types, the mutant strains tested here were not only ts mutants but also host range mutants.
In the animal model, guinea pigs were highly susceptible to WT virus infection. The mortality rate and severity of clinical disease were dose dependent ( Table 2 ). In contrast, the ts mutants were markedly different in virulence. A dose of mutant virus at an infectivity titer similar to that of WT virus produced few lesions and low mortality ( Table 3 ). The death rate was greatest in the C2b group (17%), but none of these animals developed herpetic vesicles. The ts mutant Alb had the highest frequency of lesions (40%); however, the appearance of lesions could not be correlated with mortality. Similarly, there was no relation between the lesions and death in animals inoculated with D6b and F3b mutants.
The quantity of virus and the frequency of virus isolations from serial vaginal swabs suggested variations among the mutants in the rate of in vivo virus replication. These differences may serve as important indicators in the ability of particular strains to produce clinical disease, although variations may have occurred among individual animals since only randomly bred guinea pigs were used.
Since the body temperature of the guinea pig (39 to 400C) is slightly higher than the restrictive temperature of the mutants (38°C), the ability of the virus to cause disease or to become latent may have been affected. The higher body temperature of the guinea pig may account for the reduced pathogenicity of mutants in this animal model, whereas in GPE monolayers at 38°C ts mutants replicated to a limited extent. This phenomenon in which replication is reduced even for WT virus above the nonpermissive temperature was observed by others (3). Whether there is any relationship between the capacity to induce lesions and subsequent latency at nonpermissive temperature is an intriguing question which needs further investigation.
The extremely mild clinical disease and remarkably low frequency of ts mutants recovered from tissues during both acute and latent infections indicated that the four mutant viruses used in the present experiments had a low degree of pathogenicity in guinea pigs. The failure to isolate any large numbers of WT virus indicated that the mild disease produced by mutants was a consequence of ts virus and not ts+ revertant virus.
In view of the disparate nature of the pathogenicity of HSV-2 ts mutants in tissue culture and in guinea pigs, the phenotypic characteristics of TK and deoxyribonucleic acid synthesis at the nonpermissive temperature were considered in the animal model ( 
